West Pharmaceutical Services Inc. | Mutual Funds
Mutual Funds that own West Pharmaceutical Services Inc.
T Rowe Price New Horizons Fund
3,302,800
4.49%
-8,600
1.58%
06/30/2018
Franklin Rising Dividends Fund
3,141,600
4.26%
0
1.85%
03/31/2018
Neuberger Berman Genesis Fund
2,146,029
2.92%
-64,555
2.15%
06/30/2018
iShares Core S&P Mid Cap ETF
2,015,111
2.74%
1,628
0.47%
09/06/2018
Vanguard Total Stock Market Index Fund
1,859,087
2.52%
1,840
0.03%
07/31/2018
Vanguard Small Cap Index Fund
1,851,140
2.52%
23,735
0.22%
07/31/2018
T Rowe Price Mid Cap Growth Fund
1,500,000
2.04%
0
0.53%
06/30/2018
Vanguard Small Cap Growth Index Fund
1,055,344
1.44%
14,368
0.48%
07/31/2018
Vanguard Extended Market Index Fund
975,054
1.33%
15,400
0.16%
07/31/2018
JPMorgan Small Cap Equity Fund
962,184
1.31%
-180,229
1.57%
07/31/2018
| Address |
530 Herman O. West Drive
Exton Pennsylvania 19341
United States
|
|
Employees
|
- |
| Website |
http://www.westpharma.com |
| Updated |
07/08/2019 |
| West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. |
